Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STELLAR: Fluorescence-guided Surgery in Laryngeal- and Hypopharyngeal Cancer
NCT05752149Phase 2Recruiting
- Sponsor
- Erasmus MC
- Start
- Mar 2026
- Primary completion
- Mar 2028
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of cRGD-ZW800-1 in squamous cell carcinoma of the larynx (SCCL), squamous cell carcinoma of the hypopharynx, sponsored by Erasmus MC. Started Mar 2026; status: recruiting.
02
Drugs
cRGD-ZW800-1
03
Conditions
squamous cell carcinoma of the larynx (SCCL)squamous cell carcinoma of the hypopharynx
Beyond the preview
Go deeper on NCT05752149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05752149.